BIOA - BioAge Labs, Inc.

3.22
-0.070   -2.174%

Share volume: 481,293
Last Updated: 04-07-2025
Pharmaceutical Products/Pharmaceutical Preparations: 0.00%

PREVIOUS CLOSE
CHG
CHG%
$3.29
-0.07
-0.02%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
28%
Profitability 0%
Dept financing 27%
Liquidity 50%
Performance 50%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-5.29%
1 Month
-25.64%
3 Months
-36.74%
6 Months
-85.56%
1 Year
-82.41%
2 Year
-82.41%
Key data
Stock price
$3.22
P/E Ratio 
N/A
DAY RANGE
$3.03 - $3.40
EPS 
-$15.44
52 WEEK RANGE
$3.03 - $26.62
52 WEEK CHANGE
-$82.41
MARKET CAP 
0.000
YIELD 
N/A
SHARES OUTSTANDING 
0.000
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
04-15-2025
BETA 
2.42
PUBLIC FLOAT 
N/A
AVERAGE 10 VOLUME 
$409,424
AVERAGE 30 VOLUME 
$232,224
Company detail
CEO: Kristen Fortney
Region: US
Website: bioagelabs.com
Employees: 0
IPO year: 2024
Issue type:
Market: NASDAQ
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

We are a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. We were incorporated under the laws of the State of Delaware on April 1, 2015, under the name BioAge Labs, Inc. Our principal executive offices are located at 1445A South 50th Street, Richmond, California.

Recent news
loading